title: Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.
abstract: 1. Selected Ca-channel antagonists were tested at 20 microM as inhibitors of Ca(2+)-uptake in human sickle red cells. Nitrendipine, fendiline, and bepridil (and its stereoisomers), were found to be as effective as methoxyverapamil (D-600) in inhibiting a fraction (25%) of Ca(2+)-uptake. In contrast cetiedil and Org 30701 were ineffective. 2. The drugs were subsequently tested as inhibitors of Ca(2+)-induced K+ efflux (Gardos) from sickle cells. They all showed inhibitory activity, with the order of efficacy nitrendipine greater than fendiline greater than bepridil greater than cetiedil greater than Org 30701. 3. With a 15 h programme of deoxygenation/reoxygenation cycles in a gas exchanger, it was shown that the inhibitors protected against cellular dehydration and loss of filterability in the order nitrendipine greater than fendiline greater than bepridil greater than cetiedil greater than Org 30701. However, significant stomatocytosis occurred at high concentrations of cetiedil, and bepridil (including its stereoisomers and analogues) impairing cell deformability. 4. It is concluded that Ca-antagonists may partially block both Ca(2+)-uptake and Ca(2+)-induced K+ efflux. The latter pathway is significant in contributing to sickle cell dehydration and nitrendipine is the most effective inhibitor of this route.
authors.affiliation: Department of Haematology, Medical School, University of Birmingham.
authors.forename: J C
authors.initials: JC
authors.lastname: Ellory
authors.forename: G B
authors.initials: GB
authors.lastname: Nash
authors.forename: P C
authors.initials: PC
authors.lastname: Stone
authors.forename: S J
authors.initials: SJ
authors.lastname: Culliford
authors.forename: E
authors.initials: E
authors.lastname: Horwitz
authors.forename: J
authors.initials: J
authors.lastname: Stuart
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood*; D001381:Azepines / Q000494:pharmacology; D015764:Bepridil / Q000494:pharmacology; D002118:Calcium / Q000097:blood / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004913:Erythrocytes, Abnormal / Q000187:drug effects*; D005275:Fendiline / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009568:Nitrendipine / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects
chemical_list: D001381:Azepines; D002121:Calcium Channel Blockers; D015221:Potassium Channels; C006955:cetiedil; D015764:Bepridil; D009568:Nitrendipine; D005275:Fendiline; D010100:Oxygen; D002118:Calcium